Home
/
United Health Products, Inc.
/
Financials
/
Quarterly
United Health Products, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that United Health Products, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$0
Nov 14, 2025
Q2
2025
Jun 30, 2025
$0
Aug 14, 2025
Q1
2025
Mar 31, 2025
$0
May 5, 2025
Q3
2025
Sep 30, 2024
$0
Nov 14, 2025
Q2
2025
Jun 30, 2024
$0
Aug 14, 2025
Q1
2025
Mar 31, 2024
$0
May 5, 2025
Q3
2024
Sep 30, 2023
$0
Nov 12, 2024
Q2
2024
Jun 30, 2023
$0
Aug 13, 2024
Q1
2024
Mar 31, 2023
$0
May 9, 2024
Q3
2023
Sep 30, 2022
$37.5K
Nov 13, 2023
Q2
2023
Jun 30, 2022
$0
Aug 9, 2023
Q1
2023
Mar 31, 2022
$0
May 8, 2023
Q3
2022
Sep 30, 2021
$0
Nov 14, 2022
Q2
2022
Jun 30, 2021
$0
Aug 15, 2022
Q1
2022
Mar 31, 2021
$59
May 16, 2022
Q3
2021
Sep 30, 2020
$136
Nov 5, 2021
Q2
2021
Jun 30, 2020
$136
Aug 16, 2021
Q1
2021
Mar 31, 2020
$291
May 12, 2021
Q3
2020
Sep 30, 2019
$0
Nov 13, 2020
Q2
2020
Jun 30, 2019
$4.9K
Aug 7, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($285.6K)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($315.2K)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($315.2K)
Nov 14, 2025
Q3
2025
Mar 31, 2025
($1.53M)
Nov 14, 2025
Q1
2025
Mar 31, 2025
($1.53M)
May 5, 2025
Q2
2025
Mar 31, 2025
($1.53M)
Aug 14, 2025
Q3
2025
Sep 30, 2024
($303.7K)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($432.0K)
Aug 14, 2025
Q3
2025
Jun 30, 2024
($432.0K)
Nov 14, 2025
Q3
2025
Mar 31, 2024
($451.9K)
Nov 14, 2025
Q2
2025
Mar 31, 2024
($451.9K)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($451.9K)
May 5, 2025
Q3
2024
Sep 30, 2023
($485.7K)
Nov 12, 2024
Q3
2024
Jun 30, 2023
($522.9K)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($522.9K)
Aug 13, 2024
Q3
2024
Mar 31, 2023
($1.14M)
Nov 12, 2024
Q1
2024
Mar 31, 2023
($1.14M)
May 9, 2024
Q2
2024
Mar 31, 2023
($1.14M)
Aug 13, 2024
Q3
2023
Sep 30, 2022
$820.6K
Nov 13, 2023
Q2
2023
Jun 30, 2022
($879.0K)
Aug 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($233.2K)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($268.4K)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($1.49M)
May 5, 2025
Q3
2025
Sep 30, 2024
($391.9K)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($405.2K)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($425.1K)
May 5, 2025
Q3
2024
Sep 30, 2023
($450.5K)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($475.5K)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($1.05M)
May 9, 2024
Q3
2023
Sep 30, 2022
($539.2K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($754.8K)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($954.5K)
May 8, 2023
Q3
2022
Sep 30, 2021
($724.4K)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($1.30M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($26.71M)
May 16, 2022
Q3
2021
Sep 30, 2020
($9.11M)
Nov 5, 2021
Q2
2021
Jun 30, 2020
($647.9K)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($623.8K)
May 12, 2021
Q3
2020
Sep 30, 2019
($478.7K)
Nov 13, 2020
Q2
2020
Jun 30, 2019
($604.3K)
Aug 7, 2020